NASDAQ$SMLR
Semler Scientific Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Semler Scientific's Q4 2021 financial results were reported with a revenue decrease and net income decline compared to the same period in 2020.
Semler Scientific reported a decrease in revenue and a significant decline in net income for Q4 2021 compared to Q4 2020. While fixed-fee license revenues increased, variable-fee license revenues and equipment/other sales decreased. The company experienced a COVID-19 related timing change in the home-testing market.
- Q4 2021 revenues decreased by 4% to $11.5 million compared to $12.1 million in Q4 2020.
- Net income for Q4 2021 decreased by 72% to $1.5 million, or $0.18 per diluted share, compared to $5.4 million, or $0.66 per diluted share, in Q4 2020.
- Cost of revenues increased by 120% to $2.2 million due to a $1.2 million inventory write-down.
- Two largest customers comprised 48.6% and 21.7% of fourth quarter revenues.
Headline financials
Revenue & EPS history
Semler Scientific · Revenue · Quarterly
$11.5M
Forward guidance
Semler Scientific anticipates continued profitability and cash generation in 2022, with increased spending to support business growth.
Tailwinds
- Continued profitability expected
- Cash generation from operations expected
- Increased spending to support anticipated growth
- Potential for PAD risk management at the population level
- Continued adoption of QuantaFlo® by existing and new customers
Headwinds
- Uncertainty created by the ongoing COVID-19 pandemic
- Potential impact of new COVID-19 variants
- Risk factors detailed in Semler Scientific’s SEC filings
- Dependency on insurance plans licensing cardiovascular testing products
- Ability to successfully expand its product offering
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports
-0.2%
Avg return
Earnings day
-2.4%
Avg return
5 days after
-5.8%
Avg return
30 days after
54%
25 / 46 earnings
Positive
+33.6%
Q4 2014
Best reaction
-33.3%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | -10.7% | -16.0% | -25.1% | |
| Q2 2025 | -1.8% | +2.0% | -20.7% | |
| Q1 2025 | -11.4% | +17.9% | -19.3% | |
| Q4 2024 | +3.0% | -12.4% | -22.7% | |
| Q3 2024 | +27.1% | +29.9% | +106.6% | |
| Q2 2024 | -5.4% | -1.7% | -16.7% | |
| Q4 2023 | -32.7% | -36.8% | -42.5% | |
| Q3 2023 | +7.6% | — | — | |
| Q2 2023 | +7.9% | — | — | |
| Q1 2023 | +13.8% | — | — | |
| Q4 2022 | +26.9% | — | — | |
| Q3 2022 | -33.3% | — | — | |
| Q2 2022 | +19.4% | — | — | |
| Q1 2022 | -20.6% | — | — | |
| Q4 2021 | -27.3% | — | — | |
| Q3 2021 | -25.6% | — | — | |
| Q2 2021 | -2.7% | — | — | |
| Q1 2021 | +1.5% | — | — | |
| Q4 2020 | +13.6% | — | — | |
| Q3 2020 | +10.0% | — | — | |
| Q2 2020 | -3.6% | — | — | |
| Q1 2020 | -2.6% | — | — | |
| Q4 2019 | +1.8% | — | — | |
| Q3 2019 | +1.7% | — | — | |
| Q2 2019 | +1.5% | — | — | |
| Q1 2019 | -2.7% | — | — | |
| Q4 2018 | +4.8% | — | — | |
| Q3 2018 | -12.5% | — | — | |
| Q2 2018 | +20.6% | — | — | |
| Q1 2018 | +6.4% | — | — | |
| Q4 2017 | +2.5% | — | — | |
| Q3 2017 | +16.0% | — | — | |
| Q2 2017 | -5.9% | — | — | |
| Q1 2017 | +1.5% | — | — | |
| Q4 2016 | +7.9% | — | — | |
| Q3 2016 | -16.0% | — | — | |
| Q2 2016 | +8.1% | — | — | |
| Q1 2016 | -9.2% | — | — | |
| Q4 2015 | -7.9% | — | — | |
| Q3 2015 | +0.1% | — | — | |
| Q2 2015 | -12.2% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2014 | +33.6% | — | — | |
| Q3 2014 | -3.7% | — | — | |
| Q2 2014 | -2.0% | — | — | |
| Q1 2014 | +1.2% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro